Trial intelligence / Profile preview

Prevnar 13 in Healthy Infants in Mexico

NCT00708682Phase 3Completed

Sponsor
Pfizer
Start
Jul 2008
Primary completion
May 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Prevnar 13 in pneumococcal disease, sponsored by Pfizer. Started Jul 2008; status: completed.

02

Drugs

Prevnar 13
03

Conditions

pneumococcal disease

Beyond the preview

Go deeper on NCT00708682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00708682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call